Moreover, survivin expression has been shown to correlate with aggressive behavior and prognosis in malignant neoplasms, including canine osteosarcoma [13], [19], [20], and has been proposed as an effective therapeutic target for canine osteosarcoma [13]. This evidence concerns the gene BIRC5 and cancer.